The role of adaptive immunity in atherosclerosis

Annals of the New York Academy of Sciences

Volumn 902, Issue , 2000, Pages 53-64

  Hansson, Göran K ^a   Zhou, Xinghua ^a   Törnquist, Elisabeth ^a   Paulsson, Gabrielle ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; AUTOANTIGEN; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; POLYCLONAL ANTIBODY; T LYMPHOCYTE RECEPTOR;

ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELLULAR IMMUNITY; CONFERENCE PAPER; DISEASE COURSE; HEMODYNAMICS; HUMAN; HYPERCHOLESTEROLEMIA; IMMUNE RESPONSE; IMMUNOMODULATION; KNOCKOUT MOUSE; LIPID METABOLISM; NONHUMAN; T LYMPHOCYTE;

ANIMALIA; CHLAMYDIA; CHLAMYDOPHILA PNEUMONIAE;

EID: 0034121769     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06300.x     Document Type: Conference Paper

References (44)

1. 1. HANSSON, G.K. 1997. Cell-mediated immunity in atherosclerosis. Curr. Opin. Lipidol. 8: 301-311.
2. 2. Ross, R. 1999. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340: 115-126.
3. 3. BRESLOW, J.L. 1996. Mouse models of atherosclerosis. Science 272: 685-688.
4. 4. PlEDRAHITA, J.A., S.H. ZHANG, J.R. HAGAMAN, P.M. OLIVER & N. MAEDA. 1992. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc. Natl. Acad. Sci. USA 89: 4471-4475.
5. 5. PLUMP, A.S., J.D. SMITH, T. HAYEK et al. 1992. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71: 343-353.
6. 6. ISHIBASHI, S., J. HERZ, N. MAEDA, J.L. GOLDSTEIN & M.S. BROWN. 1994. The two-receptor model of lipoprotein clearance: Tests of the hypothesis in "knockout" mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins. Proc. Natl. Acad. Sci. USA 91: 4431-4435.
7. 7. DANSKY, H.M., S.A. CHARLTON, M.M. HARPER & J.D. SMITH. 1997. T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc. Natl. Acad. Sci. USA 94: 4642-4646.
8. 8. GUPTA, S., A.M. PABLO, X.C. JIANG, N. WANG, A.R. TALL & C. SCHINDLER. 1997. IFN-γ potentiates atherosclerosis in apoE knock-out mice. J. Clin. Invest. 99: 2752-2561.
9. 9. MOSMANN, T.R. & S. SAD. 1996. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 17(3): 138-146.
10. 10. ZHOU, X., G. PAULSSON, S. STEMME & G.K. HANSSON. 1998. Hypercholesterolemia is associated with a Th1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice. J. Clin. Invest. 101: 1717-1725.
11. 11. PAIGEN, B., A. MORROW, C. BRANDON, D. MITCHELL & P.A. HOLMES. 1985. Variation in susceptibility to atherosclerosis among inbred strains of mice. Atherosclerosis 57: 65-73.
12. 12. NICOLETTI, A., S. KAVERI, G. CALIGIURI, J. BARIÉTY & G.K. HANSSON. 1998. Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice. J. Clin. Invest. 102: 910-918.
13. 13. KAZATCHKINE, N.M. & S.V. KAVERI. 1999. Immunomodulation of autoimmune disease with normal polyspecific immunoglobulin G (intravenous immunoglobulin). In The Decade of Autoimmunity. Y. Shoenfeld, Ed.: 409-419. Elsevier. Amsterdam.
14. 14. MACH, F., U. SCHONBECK, G.K. SUKHOVA, T. BOURCIER, J.Y. BONNEFOY, J.S. POBER & P. LIBBY. 1997. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages - implications for CD40-CD40 ligand signaling in atherosclerosis. Proc. Natl. Acad. Sci. USA 94: 1931-1936.
15. 15. MACH, F., U. SCHONBECK, G. K. SUKHOVA, E. ATKINSON & P. LIBBY. 1997. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 394: 200-203.
16. 16. STEINBERG, D. 1997. Low density lipoprotein oxidation and its pathobiological significance. J. Biol. Chem. 272: 20963-20966.
17. 17. WATSON, A.D., N. LEITINGER, M. NAVAB, K.F. FAULL, S. HÖRKKÖ, J.L. WITZTUM, W. PALINSKI, D. SCHWENKE, R.G. SALOMON, W. SHA, G. SUBBANAGOUNDER, A.M. FOGELMAN & J.A. BERLINER. 1997. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J. Biol. Chem. 272: 3597-13607.
18. 18. NAVAB, M., J.A. BERLINER, A.D. WATSON et al. 1996. The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture. Arterioscler. Thromb. Vasc. Biol. 16(7): 831-842.
19. 19. KUME, N., M.I. CYBULSKY & M.A. GIMBRONE. 1992. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J. Clin. Invest. 90: 1138-1144.
20. 20. MATTSSON-HULTÉN, L., H. LINDMARK, U. DICZFALUSY, I. BJÖRKHEM, M. OTTOSSON, Y. LIU, G. BONDJERS & O. WIKLUND. 1996. Oxysterols present in atherosclerotic tissue decrease the expression of lipoprotein lipase messenger RNA in human monocyte-derived macrophages. J. Clin. Invest. 97: 461-468.
21. 21. SEIFERT, P.S., F. HUGO, J.J. TRANUM, U. ZHRINGER, M. MUHLY & S. BHAKDI. 1990. Isolation and characterization of a complement-activating lipid extracted from human atherosclerotic lesions. J. Exp. Med. 172: 547-557.
22. 22. PALINSKI, W., S. YLÄ-HERTTUALA, M.E. ROSENFELD et al. 1990. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arterioscl. Thromb. 10: 325-335.
23. 23. HÖRKKÖ, S., E. MILLER, E. DUDL, P. REAVEN, L.K. CURTISS, N.J. ZVAIFLER, R. TERKELTAUB, S.S. PIERANGELI, D.W. BRANCH, W. PALINSKI & J.L. WITZTUM. 1996. Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. J. Clin. Invest. 98: 815-825.
24. 24. YLÄ-HERTTUALA, S., W. PALINSKI, M.E. ROSENFELD et al. 1989. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84: 1086-1095.
25. 25. WITZTUM, J.L. & D. STEINBERG. 1991. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88: 1785-1792.
26. 26. GRIFFITH, R.L., G.T. VIRELLA, H.C. STEVENSON & V.M. LOPES. 1988. Low density lipoprotein metabolism by human macrophages activated with low density lipoprotein immune complexes. A possible mechanism of foam cell formation. J. Exp. Med. 168: 1041-1059.
27. 27. HOLVOET, P., G. PEREZ, Z. ZHAO, E. BROUWERS, H. BEMAR & D. COLLEN. 1995. Malondialdehyde modified low density lipoprotein in patients with atherosclerotic disease. J. Clin. Invest. 95: 2611-2619.
28. 28. PALINSKI, W., S. HÖRKKÖ, E. MILLER et al. 1996. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J. Clin. Invest. 98(3): 800-814.
29. 29. STEMME, S., J. HOLM & G.K. HANSSON. 1992. T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. Arterioscl. Thromb. 12: 206-211.
30. 30. PAULSSON, G., X. ZHOU, E. TÖRNQUIST & G.K. HANSSON. 2000. Oligoclonal T cell expansions in atherosclerotic lesions of apoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 20: 10-17.
31. 31. FREIGANG, S., S. HÖRKKÖ, E. MILLER, J.L. WITZTUM & W. PALINSKI. 1998. Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes. Arterioscl. Thromb. Vasc. Biol. 18: 1972-1982.
32. 32. STEMME, S., L. RYMO & G.K. HANSSON. 1991. Polyclonal origin of T lymphocytes in human atherosclerotic plaques. Lab. Invest. 65(654): 654-660.
33. 33. SWANSON, S.J., A. ROSENZWEIG, J.G. SEIDMAN & P. LIBBY. 1994. Diversity of T-cell antigen receptor V - gene utilization in advanced human atheroma. Arterioscl. Thromb. 14: 1210-1214.
34. 34. NICOLETTI, A., G. CALIGIURI, I. TÖRNBERG, K. KODAMA, S. STEMME & G.K. HANSSON. 1999. The macrophage scavenger receptor type A directs modified proteins to antigen presentation. Eur. J. Immunol. 29: 512-521.
35. 35. SALONEN, J.T., S. YLÄ-HERTTUALA, R. YAMAMOTO et al. 1992. Autoantibody against oxidized LDL and progression of carotid atherosclerosis. Lancet 339: 883-887.
36. 36. BERGMARK, C., R. Wu, U. DE FAIRE, A.K. LEFVERT & J. SWEDENBORG. 1995. Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL. Arterioscler. Thromb. Vasc. Biol. 15: 441-445.
37. 37. PALINSKI, W., E. MILLER & J.L. WITZTUM. 1995. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc. Natl. Acad. Sci. USA 92: 821-825.
38. 38. AMELI, S., A. HULTGARDH-NILSSON, J. REGNSTRÖM et al. 1996. Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits. Arterioscl. Thromb. Vasc. Biol. 16: 1074-1079.
39. 39. GEORGE, J., A. AFEK, B. GILBURD, H. LEVKOVITZ, A. SHAISH, I. GOLDBERG, Y. KOPOLOVIC, G. WICK, Y. SHOENFELD & D. HARATS. 1998. Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis. Atherosclerosis 138: 147-152.
40. 40. WICK, G., G. SCHETT, A. AMBERGER, R. KLEINDIENST & Q. XU. 1995. Is atherosclerosis an immunologically mediated disease? Immunol. Today 16: 27-33.
41. 41. MAYR, M., B. METZLER, S. KIECHL, J. WILLEIT, G. SCHETT, Q. Xu & G. WICK. 1999. Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae: immune reactions to heat shock proteins as a possible link between infection and atherosclerosis. Circulation 99: 1560-1566.
42. 42. Kuo, C.C., A.M. GOWN, E.P. BENDITT & J.T. GRAYSTON. 1993. Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscl. Thromb. 13: 1501-1504.
43. 43. MUHLESTEIN, J.B., J.L. ANDERSON, E.H. HAMMOND, L. ZHAO, S. TREHAN, E.P. SCHWOBE & J.F. CARLQUIST. 1998. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 24: 633-636.
44. 44. MOAZED, T.C., L.A. CAMPBELL, M.E. ROSENFELD, J.T. GRAYSTON & C.C. Kuo. Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. J. Infect. Dis. 180: 238-241.